Chinook Therapeutics Inc

NASDAQ:KDNY  
15.40
+1.52 (+10.95%)
Earnings Announcements

Chinook Therapeutics Reports Q4 And FY 2021 Financial Results

Published: 03/17/2022 20:08 GMT
Chinook Therapeutics Inc (KDNY) - Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results.
Chinook Therapeutics Inc- Cash, Cash Equivalents and Marketable Securities Totaled $355.1 Million at December 31, 2021.
Chinook Therapeutics Inc - Qtrly Earnings per Share $0.14.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.